Industry News

Theradex launches Clinical Trial Management System (CTMS)

March 2018

Theradex Oncology Announces Advanced Functionality for Clinical Trial Management System Theradex Oncology, a leading global provider in early-phase oncology management services, today announced the release of their proprietary clinical trial management system (CTMS), that combines data, processes, and reports on a single platform, and provides real-time access to analytics allowing... read more »

Attending ASCO Annual Meeting- Chicago, IL

June 2017

Exhibiting 02-06Jun2017... read more »

Attending AACR Annual- Washington D.C.

April 2017

Exhibiting 01-05Apr2017 Booth #1219... read more »

Attending ASCO Annual Meeting Chicago, IL

June 2016

Come meet the Theradex team at ASCO Annual Meeting, June 3-7, 2016 McCormick Place Chicago, Illinois. Booth: 17109 ... read more »

JCO Publication- Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical Trials

February 2016

Full text- ... read more »

Attending AACR Annual Meeting New Orleans

April 2016

Don't miss Theradex at AACR Annual Meeting New Orleans, LA April 16-20th  Booth:1022 ... read more »

Theradex at The American Society of Hematology Meeting

December 2015

Theradex will be at The American Society of Hematology Meeting December 4-8th Orlando, FL Dr. Barry Anderson will be available to meet. ... read more »

Theradex Team Receives NCI Award of Merit

November 2015

Theradex team members receive National Institutes of Health National Cancer Institute Award of MeritNCI ETCTN Implementation Working GroupImplementation of NCI Experimental Therapeutics Clinical Trials Network (ETCT)-Development of a web-based reporting system and drug development teams to support the ETCTN. ... read more »

Attending AACR- NCI- EORTC International Conference

November 2015

Theradex will be attending the AACR- NCI- EORTC International Conference on Molecular Targets and Cancer Therapeutics this November 5th-9th in Boston, MA ... read more »

JCO Publication- Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program-Sponsored Single-Agent Phase I Studies

October 2015

Full text: ... read more »

Theradex Partners with Rich Pharmaceuticals

October 2015

BEVERLY HILLS, Calif., Oct. 7, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc. (OTCPK: RCHA) ("Rich" or the "Company") announced today it has entered into an agreement with Theradex Systems, Inc. ("Theradex"), a leading global contract research organization ("CRO") with extensive expertise in oncology clinical development. Through this new partnership, Theradex... read more »

AACR - Corporate/Foundation Partners

September 2014

AACR Corporate/Foundation Partners: We greatly appreciate the contributions of our sustaining members and other corporate and foundation partners. To learn more about how your company can support the AACR, contact Iain Mitchell via email or 215-446-7120. For more information about foundation partnerships, contact Jessica Cestone via email or 215-446-7211.   THERADEX REMAINS A MAJOR... read more »

Theradex Staff Receive NCI Recognition

December 2014

Theradex Staff receive National Cancer Institute Certificate of Recognition read more »